Could ultrasound replace radioactive dye for cancer staging?

NCT ID NCT07310758

Recruiting now Diagnosis Sponsor: The Netherlands Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a special ultrasound using a contrast agent (Sonazoid) can find sentinel lymph nodes as accurately as the standard radioactive tracer method in people with melanoma, breast cancer, or head & neck cancer. About 91 adults will take part, and the goal is to see if the ultrasound method is sensitive enough to replace the radioactive approach. If successful, it could offer a safer, needle-free option for cancer staging.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm head and neck cancer Head and Neck Neoplasms melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER HEAD NECK CANCER MELANOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Netherlands Cancer Institute
RECRUITING

Amsterdam, North Holland, 1066 CX, Netherlands

Contact Phone: •••-•••-•••• Email: •••••@•••••